News
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
News-Medical.Net on MSN1d
Tirzepatide outperforms semaglutide for weight loss in people without diabetesA head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...
Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.
Verywell Health on MSN8h
Could Wegovy Cause Hair Loss?People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...
GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback